Funding Round attributes
mediaire, a Berlin-based company specializing in AI-powered diagnostic solutions for MRI imaging, has raised €12 million in a funding round led by LBO France, with participation from IBB Ventures, Wille Finance, HTGF, LIFTT, and Gateway Ventures. The funding will enable mediaire to accelerate its growth, expand its product offerings, and enhance the integration of artificial intelligence into clinical workflows.
Founded to streamline MRI diagnostics, mediaire’s AI solutions, including its flagship mdbrain, mdprostate, and mdknee, help radiologists with accurate analysis across brain, prostate, and knee imaging. Currently used in over 350 hospitals and clinics across Europe, mediaire's technology integrates directly into clinical workflows, reducing radiologists’ workloads and providing faster diagnostic results for patients.
CEO Dr. Andreas Lemke noted the transformative impact of mediaire’s technology, saying, “Our AI solutions are not a futuristic dream. We have already created a reality that is helping doctors make better decisions and giving patients faster answers.” The recent investment will enable mediaire to scale these benefits further, expanding its AI portfolio beyond current MRI applications to address more diagnostic needs in global healthcare.
Investment Director Matthes Seeling from LBO France commented on the synergy between mediaire’s vision and the firm’s investment strategy. “We believe in the power of technology to improve lives,” said Seeling. “mediaire’s focus aligns perfectly with our firm belief in the transformative power of healthcare technology to the benefit of all professionals and patients.”
This financing round marks a significant step forward in mediaire’s mission to support radiologists and optimize healthcare delivery worldwide, underscoring the company’s commitment to advancing medical AI.
